Antibody-drug conjugates

World Antibody-Drug Conjugate Summit, October 15–16, 2013, San Francisco, CA

(2013) Christine Klinguer-Hamour et al.   mAbs

8thAnnual European Antibody Congress 2012

(2013) Alain Beck et al.   mAbs

Site-specific antibody drug conjugates for cancer therapy

(2013) Siler Panowski et al.   mAbs

In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap

(2013) Sara Rosati et al.   mAbs

Characterization of Therapeutic Antibodies and Related Products

(2012) Alain Beck et al.   ANALYTICAL CHEMISTRY

Fourth World Antibody-Drug Conjugate Summit

(2012) Alain Beck et al.   mAbs

7th Annual European Antibody Congress 2011

(2012) Alexey A. Lugovskoy et al.   mAbs

2ndPEGS Annual Symposium on Antibodies for Cancer Therapy

(2012) Mitchell Ho et al.   mAbs

7th Cancer Scientific Forum of the Cancéropôle Lyon Auvergne Rhône-Alpes

(2012) Petrus J. Pauwels et al.   mAbs

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates

(2012) Ben-Quan Shen et al.   NATURE BIOTECHNOLOGY

6thAnnual European Antibody Congress 2010

(2011) Alain Beck et al.   mAbs

World Antibody Drug Conjugate Summit Europe

(2011) Alain Beck et al.   mAbs

Analytical methods for physicochemical characterization of antibody drug conjugates

(2011) Aditya Wakankar et al.   mAbs

4th European Antibody Congress 2008: December 1-3, 2008, Geneva, Switzerland

(2010) Alain Beck et al.   mAbs

5th European Antibody Congress 2009

(2010) Alain Beck et al.   mAbs

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

(2008) Jagath R Junutula et al.   NATURE BIOTECHNOLOGY